A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

Por Boss, D S, Glen, H, Beijnen, J H, Keesen, M, Morrison, R, Tait, B, Copalu, W, Mazur, A, Wanders, J, O'Brien, J P, Schellens, J H M, Evans, T R J
Publicado em 2012